chrX-53546527-G-C
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_031407.7(HUWE1):āc.10824C>Gā(p.Leu3608Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000111 in 1,207,255 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 46 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_031407.7 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HUWE1 | NM_031407.7 | c.10824C>G | p.Leu3608Leu | synonymous_variant | 70/84 | ENST00000262854.11 | NP_113584.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HUWE1 | ENST00000262854.11 | c.10824C>G | p.Leu3608Leu | synonymous_variant | 70/84 | 1 | NM_031407.7 | ENSP00000262854.6 |
Frequencies
GnomAD3 genomes AF: 0.000170 AC: 19AN: 111907Hom.: 0 Cov.: 22 AF XY: 0.000176 AC XY: 6AN XY: 34055
GnomAD3 exomes AF: 0.000408 AC: 73AN: 179031Hom.: 0 AF XY: 0.000392 AC XY: 25AN XY: 63705
GnomAD4 exome AF: 0.000105 AC: 115AN: 1095296Hom.: 0 Cov.: 31 AF XY: 0.000111 AC XY: 40AN XY: 360716
GnomAD4 genome AF: 0.000170 AC: 19AN: 111959Hom.: 0 Cov.: 22 AF XY: 0.000176 AC XY: 6AN XY: 34117
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Apr 09, 2019 | - - |
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 04, 2017 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 29, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at